Dave Rushton
Founder
of Paradigm Shift Consulting Limited.
Dave Rushton is Founder of Paradigm Shift Consulting Limited, a Good Distribution Practice Consultancy.
Blog
Take a look through our free blogs that cover a number of different areas of Good Distribution Practice (GDP). Each blog addresses primary topics including training, inspections and procedures. If you need any more information or any assistance/training don’t hesitate to contact us by email or phone.
Good Distribution Practice for Veterinary Medicines
Understanding Good Distribution Practice for Veterinary Medicines in Great Britain In June 2025, the Veterinary Medicines Directorate (VMD) introduced the Good Distribution Practice (GDP) for Veterinary Medicinal Products in Great Britain guidelines. This move brings greater regulatory clarity and...
The Real Costs of a WDA: What No One Tells You About Pricing in 2026
WDA(H) Application Costs: What Pharmacies & Pharmaceutical Distributors Need to Know (Update) In the world of pharmaceutical wholesale and distribution, compliance with EU GDP Guidelines, not least holding a valid WDA(H) licence, is essential.Yet Paradigm Shift consultants have found that...
Why GDP Matters to Pharmaceutical Wholesalers
The Importance of GDP Guidelines from Manufacture to Wholesale The quality and safety of medicines depend not only on how they are manufactured, but also on how they are distributed throughout the supply chain by pharmaceutical wholesale distributors, and this is where Good Distribution Practice...
Finalists for North Northamptonshire Business of the Year Award 2025!
Paradigm Shift Consulting Ltd: North Northants Business of the Year 2025 - Finalists Paradigm Shift Consulting Ltd are thrilled to share some exciting news:We have been named as finalists for the North Northamptonshire Business of the Year Award at the prestigious Northamptonshire Business Awards...
ALCOA++ and the Future of Data Integrity in GDP
Why ALCOA++ Matters in Good Documentation Practices (GDP) In the pharmaceutical supply chain, documentation is more than just paperwork, it is the core of product quality, patient safety, and regulatory compliance.As we move further into an era of digital records and increasingly complex...
UK Pharma Industry Awards Winners 2025
Paradigm Shift Consulting Wins the Pharma Industry Awards UK 2025 – Pharma Education and Training AwardWe are beyond thrilled to share that Paradigm Shift Consulting Ltd, has won the Pharma Education and Training Award at the Pharma Industry Awards UK 2025 for the cost-effective training on their...
Why Staying Up to Speed with GDP Matters
Introduction The GDP pharmaceutical supply chain is one of the most tightly regulated sectors in the UK and across Europe, and for good reason.Medicinal products are not like other consumer products. They are extremely sensitive products; any compromise in their quality, safety or efficacy can...
Closing Meetings: What to expect from the MHRA Inspector
A closing meeting overview following an MHRA GDP Inspection A closing meeting following a third party, MHRA (Medicines and Healthcare products Regulatory Agency) audit, most commonly referred to as an inspection, is a critical part of the inspection process. It serves as a formal opportunity for...
MHRA Inspection: Are You Ready?
Being ready for the MHRA inspector Does your organisation go into panic mode the second you receive notification from the MHRA that they are coming to perform an inspection on your quality systems? Do your quality team frantically start pulling 5 years’ worth of documents from your archive area? ...
External (2nd Party) Audits: Their Importance
External (2nd Party) Audits If you’re a UK wholesale distributor of medicinal products, maintaining compliance with Good Distribution Practice (GDP) is not just a regulatory obligation, it is a core part of safeguarding patient safety and product integrity. GDP guidelines, issued by the European...